| Not Yet Recruiting | Efficacy and Safety of QL1706 Combined With Nab-paclitaxel and Cisplatin as 1st Line Therapy for Advanced or M QL1706, ESCC, First-line Therapy | Phase 2 | 2026-05-01 |
| Recruiting | A Single-Center, Open-Label, Single Ascending Dose Study of Exenatide Circular RNA-Lipid Nanoparticle Injectio T2DM | EARLY_Phase 1 | 2026-01-20 |
| Not Yet Recruiting | Clinical Study on the Effect of Removal of Porphyromonas Gingivalis on Prognosis of Esophageal Cancer After Ra Evaluate the DFS of Patients With Esophageal Cancer Who Underwent Radical Operation After Regular Removal of Porphyromonas Gingivalis | Phase 3 | 2024-08-01 |
| Not Yet Recruiting | Adebrelimab in Combination With Apatinib and Chemotherapy/Chemoradiotherapy in Immuno-experienced Second-line Esophageal Cancer | Phase 2 | 2024-07-15 |
| Active Not Recruiting | Clinical Study on the Impact of Eradication of Oral Porphyromonas Gingivalis on the Prognosis of Early Esophag Esophageal Cancer | N/A | 2024-05-01 |
| Unknown | A Comparative Study of Endoscopic Submucosal Dissection and Photodynamic Therapy for Early Esophageal Cancer Esophageal Carcinoma in Situ AJCC V7 | N/A | 2022-03-01 |
| Unknown | Alflutinib Versus Alflutinib Plus Chemotherapy for NSCLC NSCLC | Phase 2 / Phase 3 | 2022-03-01 |
| Unknown | Influence of Different Light Dose on the Adverse Effect of Swallowing for Esophageal Carcinoma Esophagus Cancer | N/A | 2022-01-01 |
| Unknown | Camrelizumab Combined With CRT for Treatment of Patients With Local Recurrence of Esophageal Cancer Esophageal Cancer | Phase 2 | 2021-12-01 |
| Unknown | Clinical Control Study of Immunotherapy and Concurrent Chemoradiotherapy in Patients With Esophageal Cancer Re Esophageal Malignant Neoplasm, Local Recurrence | Phase 3 | 2020-06-01 |
| Unknown | GASC1 Inhibitor Caffeic Acid for Squamous Esophageal Cell Cancer (ESCC) Esophagus Cancer, Stage III | Phase 3 | 2019-05-01 |
| Unknown | The Efficacy and Safety of Caffeic Acid for Esophageal Cancer Esophagus Cancer | Phase 3 | 2017-01-01 |
| Recruiting | Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer Esophagus Cancer | N/A | 2016-11-01 |
| Unknown | Identification of Ventricular Fibrillation and Optimization of Defibrillation During CPR Cardiac Arrest, Identify of Electrocadiac Rhythm | — | 2016-04-01 |
| Unknown | Clinical Study of Time Optimizing of Endoscopic Photodynamic Therapy on Esophageal and/or Gastric Cardiac Canc Stage I Esophageal Adenocarcinoma, Stage II Esophageal Adenocarcinoma, Stage III Esophageal Adenocarcinoma | Phase 3 | 2015-10-01 |
| Completed | Megestrol Acetate for the Improvement of Quality of Life in Esophageal Cancer With Chemoradiotherapy Stage III Esophageal Squamous Cell Carcinoma, Stage II Esophageal Squamous Cell Carcinoma | Phase 3 | 2014-10-01 |
| Unknown | Chemoradiotherapy of Capecitabine With or Without Oxaliplatin Versus Cisplatin-5-FU for Esophageal Squamous Ca Stage III Esophageal Squamous Cell Carcinoma, Stage II Esophageal Squamous Cell Carcinoma | Phase 3 | 2014-10-01 |
| Unknown | The Role of Different Cycles of Chemotherapy（Capecitabine-oxaliplatin） in Esophageal Chemoradiotherapy Stage III Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms | Phase 3 | 2014-10-01 |
| Unknown | Different Cycles of Capecitabine Usage in Esophageal Cancer Concurrent Chemoradiotherapy Stage III Esophageal Squamous Cell Carcinoma, Stage II Esophageal Squamous Cell Carcinoma | Phase 3 | 2014-10-01 |
| Unknown | Different Cycles of Cisplatin-5-fluorouracil for the Chemoradiotherapy of Esophageal Squamous Cancer Stage III Esophageal Squamous Cell Carcinoma, Stage II Esophageal Squamous Cell Carcinoma | Phase 3 | 2014-10-01 |